Madrigal Pharmaceuticals EBIT 2010-2024 | MDGL

Madrigal Pharmaceuticals EBIT for the quarter ending September 30, 2024 was $-0.116B, a 18.03% increase year-over-year.

  • Madrigal Pharmaceuticals 2023 EBIT was -0.38B, a 29.61% increase from 2022.
  • Madrigal Pharmaceuticals 2022 EBIT was -0.294B, a 21.07% increase from 2021.
  • Madrigal Pharmaceuticals 2021 EBIT was -0.242B, a 17.33% increase from 2020.

EBIT can be defined as earnings before interest and taxes.

Madrigal Pharmaceuticals EBIT 2010-2024 | MDGL

  • Madrigal Pharmaceuticals 2023 EBIT was -0.38B, a 29.61% increase from 2022.
  • Madrigal Pharmaceuticals 2022 EBIT was -0.294B, a 21.07% increase from 2021.
  • Madrigal Pharmaceuticals 2021 EBIT was -0.242B, a 17.33% increase from 2020.

EBIT can be defined as earnings before interest and taxes.